Penserra Capital Management LLC Karyopharm Therapeutics Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$5.21 - $8.61 $8,987 - $14,852	-1,725 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.45 - $10.63 $66 - $159	15 Added 0.88%	1,725 $10,000
Q2 2021 Aug 12, 2021	BUY	$8.11 - $11.11 $121 - $166	15 Added 0.88%	1,710 $17,000
Q1 2021 May 13, 2021	BUY	$9.85 - $17.69 $49 - $88	5 Added 0.3%	1,695 $17,000
Q4 2020 Feb 12, 2021	BUY	$14.15 - $17.19 $15,027 - $18,255	1,062 Added 169.11%	1,690 $26,000
Q3 2020 Nov 13, 2020	BUY	$14.14 - $19.71 $8,879 - $12,377	628 New	628 $9,000

56.3M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $50.3M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.